NYSE · Medical - Healthcare Plans

Humana Inc. (HUM) Stock

$422.07 +0.26% NYSE: HUM Healthcare

Valuation

MetricValue
Price$422.07
Market Cap$50.68B
P/E Ratio37.38
P/B Ratio2.49
P/S Ratio0.33
EPS (TTM)$9.84
52-Week High$450.00
52-Week Low$163.11
Dividend Yield0.89%

Financials & Margins

MetricValue
ROE6.91%
ROA2.23%
ROCE5.91%
Gross Margin1.12%
Operating Margin1.12%
Net Margin0.88%
Debt/Equity0.74
Current Ratio0.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$83.6B$92.9B$106.4B$117.8B$129.7B
Operating Profit$3.4B$3.6B$3.3B$1.6B$1.5B
Net Profit$2.9B$2.8B$2.5B$1.2B$1.2B
EPS$22.67$22.08$20.00$9.98$9.84
Op Margin4.1%3.8%3.1%1.4%1.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$44.7B$43.7B$46.9B$46.3B$48.8B
Total Liabilities$28.6B$28.4B$30.6B$29.9B$31.0B
Cash$3.4B$5.1B$4.7B$2.2B$4.2B
Borrowings$13.2B$11.8B$12.3B$12.3B$12.9B

Latest News

Sector Update: Healthcare Stocks Advance Late Afternoon MT Newswires · Jul 13, 2026 Humana Shares Rise After Upgrade From Wells Fargo MT Newswires · Jul 13, 2026 Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch Zacks · Jul 13, 2026 The Premium On CVS Stock Vs What Its Peers Deliver Trefis · Jul 13, 2026 Humana Eyes 3% Medicare Advantage Margin: Can It Deliver? Zacks · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.3B$4.6B$4.0B$3.0B$921.0M
Investing Cash Flow$-7.9B$-2.1B$-4.5B$-3.5B$1.7B
Financing Cash Flow$-389.0M$-128.0M$-848.0M$-2.3B$-1.2B
Net Cash Flow$-1.3B$1.7B$-367.0M$-2.5B$2.0B
Free Cash Flow$920.0M$3.5B$3.0B$2.4B$375.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-2.02
EV / EBITDA17.97
FCF Yield-0.93%
Quick Ratio1.74
Interest Coverage2.87
Return 1Y45.37%
Return 3Y-16.02%
Return 5Y-4.18%

Ownership

Insiders Held0.21%
Institutions Held99.89%
Institutions Float Held100.10%
Institutional HolderSharesReport Date
Dodge & Cox Inc.11,380,6732026-03-31
Blackrock Inc.10,199,0552026-03-31
Vanguard Capital Management LLC7,838,7622026-03-31
Vanguard Portfolio Management LLC5,808,4352026-03-31
Pzena Investment Management LLC5,470,9822026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALHCAlignment Healthcare, Inc. $8.06 -4.39% 41.70 $1.67B 0.00%
CIThe Cigna Group $306.95 -2.83% 11.22 $81.11B 2.29%
CNCCentene Corporation $70.17 -1.50% -6.18 $34.66B 0.00%
CVSCVS Health Corporation $93.47 -1.07% 23.27 $119.55B 2.98%
ELVElevance Health, Inc. $439.95 -1.20% 17.60 $95.41B 1.74%

About Humana Inc.

Humana Inc. is led by CEO James A. Rechtin, employs 65,680 people, headquartered in Louisville, US, publicly traded since 1981.

Humana Inc. (HUM) stock trades at $422.07 with a market capitalization of $50.68B. The stock is valued at a price-to-earnings (P/E) ratio of 37.38, price-to-book of 2.49, price-to-sales of 0.33. Over the past 52 weeks the stock has ranged between $163.11 and $450.00, and currently trades 6.2% below its 52-week high. It pays a dividend yielding 0.89%.

On profitability, Humana Inc. generates a return on equity (ROE) of 6.91%, return on capital employed of 5.91%, an operating margin of 1.12%, a net profit margin of 0.88%.

In its most recent fiscal year, Humana Inc. reported annual revenue of $129.7B, net profit of $1.2B. Over the last 5 fiscal years, revenue grew at an average annual rate of 10.9%, and net profit declined at an average annual rate of 18.8%.

The balance sheet shows a debt-to-equity ratio of 0.74, a current ratio of 0.72, total assets of $48.8B, $4.2B in cash and equivalents.

HUM has an average daily trading volume of 1,377,389 shares, a beta of 0.74 (historically less volatile than the overall market).

Humana Inc. by the numbers, 2016–2025

Between 2016 and 2025 Humana Inc. reported revenue of $54.4B rising to $129.7B, a change of +138.3% across 10 years. Compounded, revenue has grown 10.9% a year over five years, 11.8% over three, 10.1% over the last twelve months. Net profit rose to $1.2B.

Operating margin went from 3.2% in 2016 to 1.1% in 2025, a fall of 2.1 percentage points. The most recent net margin is 0.88%. On a trailing twelve-month basis to Jun '26, revenue is $145.7B and net profit $1.3B.

Borrowings rose from $4.1B to $12.9B, cash from operations was $921.0M in the latest year, positive in 10 of the last 10.

Return on equity has averaged 13.2% over five years, and was 6.7% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Humana Inc. (HUM) — frequently asked questions

What is Humana Inc. (HUM) stock price today?

Humana Inc. (HUM) is currently trading at $422.07, up 0.26% today.

What is HUM P/E ratio?

Humana Inc.'s P/E ratio is 37.38. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is HUM return on equity (ROE)?

Humana Inc.'s return on equity (ROE) is 6.91%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is Humana Inc.'s market cap?

Humana Inc. has a market capitalization of $50.68B.

Does HUM pay a dividend?

Yes. Humana Inc. currently yields 0.89%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does HUM carry?

Humana Inc. has a debt-to-equity ratio of 0.74. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is HUM's profit margin?

Humana Inc. reports a net profit margin of 0.88% — the share of revenue left after every cost, including tax and interest.

What sector is HUM in?

Humana Inc. is classified under Healthcare, in the Medical - Healthcare Plans industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is HUM listed on?

Humana Inc. trades on NYSE under the ticker HUM.

What is HUM's 52-week range?

Over the last year Humana Inc. has traded between $163.11 and $450.00.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens HUM currently matches

On the figures above, Humana Inc. passes the filters for 5 of our ready-made screens, among them Large Cap Stocks, Large Cap Dividend Stocks, NYSE Listed Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Large Cap StocksLarge Cap Dividend StocksNYSE Listed StocksDebt to Equity Below 1 StocksNegative Working Capital Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.